Original Article http://dx.doi.org/10.4070/kcj.2016.46.5.719 Print ISSN 1738-5520 • On-line ISSN 1738-5555
Korean Circulation Journal
Retrospective Multicenter Study of Respiratory Syncytial Virus Prophylaxis in Korean Children with Congenital Heart Diseases Ah Young Kim, MD1, Se Yong Jung, MD1, Jae Young Choi, MD1, Gi Beom Kim, MD2, Young-Hwue Kim, MD3, Woo Sup Shim, MD4, I-Seok Kang, MD5, and Jo Won Jung, MD1 1
Yonsei University Severance Cardiovascular, Seoul, 2Seoul National University Children’s Hospital, Seoul, 3Ulsan University Asan Medical Center, Seoul, 4Gangwon National University, Chuncheon, 5Sungkyunkwan University Samsung Medical Center, Seoul, Korea
Background and Objectives: We conducted a review of current data on respiratory syncytial virus (RSV) prophylaxis with palivizumab, in Korean children with congenital heart diseases (CHD). In 2009, the Korean guideline for RSV prophylaxis had established up to five shots monthly per RSV season, only for children
Korean Circulation Journal
Retrospective Multicenter Study of Respiratory Syncytial Virus Prophylaxis in Korean Children with Congenital Heart Diseases Ah Young Kim, MD1, Se Yong Jung, MD1, Jae Young Choi, MD1, Gi Beom Kim, MD2, Young-Hwue Kim, MD3, Woo Sup Shim, MD4, I-Seok Kang, MD5, and Jo Won Jung, MD1 1
Yonsei University Severance Cardiovascular, Seoul, 2Seoul National University Children’s Hospital, Seoul, 3Ulsan University Asan Medical Center, Seoul, 4Gangwon National University, Chuncheon, 5Sungkyunkwan University Samsung Medical Center, Seoul, Korea
Background and Objectives: We conducted a review of current data on respiratory syncytial virus (RSV) prophylaxis with palivizumab, in Korean children with congenital heart diseases (CHD). In 2009, the Korean guideline for RSV prophylaxis had established up to five shots monthly per RSV season, only for children
